Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis.
Título
Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis.
Autor
Ofelia Baniandrés-Rodríguez, Jaime Vilar-Alejo, Raquel Rivera, José Manuel Carrascosa, Esteban Daudén, Enrique Herrera-Acosta, Antonio Sahuquillo-Torralba, Fran J Gómez-García, Lula María Nieto-Benito, Pablo de la Cueva, José Luis López-Estebaranz, Isabel Belinchón, Marta Ferrán Farrés, Mercè Alsina, Lourdes Rodríguez Fernández-Freire, Gregorio Carretero, Carmen García-Donoso, Ferrán Ballescá, Mar Llamas-Velasco, Enrique Herrera-Ceballos, Rafael Botella-Estrada, Diana Patricia Ruiz-Genao, Josep Riera-Monroig, Miguel Ángel Descalzo Gallego, Ignacio García-Doval
Fecha
2021
Identificador
10.1016/j.jaad.2020.10.046
Fuente
Journal of the American Academy of Dermatology
Archivos
Colección
Citación
Ofelia Baniandrés-Rodríguez, Jaime Vilar-Alejo, Raquel Rivera, José Manuel Carrascosa, Esteban Daudén, Enrique Herrera-Acosta, Antonio Sahuquillo-Torralba, Fran J Gómez-García, Lula María Nieto-Benito, Pablo de la Cueva, José Luis López-Estebaranz, Isabel Belinchón, Marta Ferrán Farrés, Mercè Alsina, Lourdes Rodríguez Fernández-Freire, Gregorio Carretero, Carmen García-Donoso, Ferrán Ballescá, Mar Llamas-Velasco, Enrique Herrera-Ceballos, Rafael Botella-Estrada, Diana Patricia Ruiz-Genao, Josep Riera-Monroig, Miguel Ángel Descalzo Gallego, Ignacio García-Doval, “Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis.,” SOCICT Open, consulta 17 de abril de 2026, https://www.socictopen.socict.org/items/show/7605.
Position: 12063 (23 views)